Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Matthew Baggott

AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Agurto C, Cecchi GA, Norel R, Ostrand R, Kirkpatrick M, Baggott MJ, Wardle MC, Wit H, Bedi G. Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing. Neuropsychopharmacology. 2020 04; 45(5):823-832. PMID: 31978933.
      View in: PubMed
    2. Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers. J Psychoactive Drugs. 2019 Apr-Jun; 51(2):108-117. PMID: 30967099.
      View in: PubMed
    3. Bershad AK, Miller MA, Baggott MJ, de Wit H. The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? J Psychopharmacol. 2016 12; 30(12):1248-1258. PMID: 27562198.
      View in: PubMed
    4. Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. MDMA Impairs Response to Water Intake in Healthy Volunteers. Adv Pharmacol Sci. 2016; 2016:2175896. PMID: 27403159.
      View in: PubMed
    5. Baggott MJ, Coyle JR, Siegrist JD, Garrison KJ, Galloway GP, Mendelson JE. Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. J Psychopharmacol. 2016 Apr; 30(4):378-87. PMID: 26880224.
      View in: PubMed
    6. Baggott MJ, Kirkpatrick MG, Bedi G, de Wit H. Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol. 2015 Jun; 29(6):669-77. PMID: 25922420.
      View in: PubMed
    7. Kirkpatrick MG, Baggott MJ, Mendelson JE, Galloway GP, Liechti ME, Hysek CM, de Wit H. MDMA effects consistent across laboratories. Psychopharmacology (Berl). 2014 Oct; 231(19):3899-905. PMID: 24633447.
      View in: PubMed
    8. Weafer J, Baggott MJ, de Wit H. Test-retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention. Exp Clin Psychopharmacol. 2013 Dec; 21(6):475-81. PMID: 24099351.
      View in: PubMed
    9. Pal R, Balt S, Erowid E, Erowid F, Baggott MJ, Mendelson J, Galloway GP. Ketamine is associated with lower urinary tract signs and symptoms. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):189-94. PMID: 23474358.
      View in: PubMed
    10. Baggott MJ, Childs E, Hart AB, de Bruin E, Palmer AA, Wilkinson JE, de Wit H. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology (Berl). 2013 Jul; 228(1):109-18. PMID: 23420115.
      View in: PubMed
    11. Balt SL, Galloway GP, Baggott MJ, Schwartz Z, Mendelson J. Mechanisms and genetics of antipsychotic-associated weight gain. Clin Pharmacol Ther. 2011 Jul; 90(1):179-83. PMID: 21633343.
      View in: PubMed
    12. Li L, Galloway GP, Verotta D, Everhart ET, Baggott MJ, Coyle JR, Lopez JC, Mendelson J. A method to quantify illicit intake of drugs from urine: methamphetamine. J Pharmacol Exp Ther. 2011 Jul; 338(1):31-6. PMID: 21450932.
      View in: PubMed
    13. Mendelson J, Baggott MJ, Flower K, Galloway G. Developing biomarkers for methamphetamine addiction. Curr Neuropharmacol. 2011 Mar; 9(1):100-3. PMID: 21886571.
      View in: PubMed
    14. Galloway GP, Buscemi R, Coyle JR, Flower K, Siegrist JD, Fiske LA, Baggott MJ, Li L, Polcin D, Chen CY, Mendelson J. A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther. 2011 Feb; 89(2):276-82. PMID: 21178989.
      View in: PubMed
    15. Mendelson JE, Coyle JR, Lopez JC, Baggott MJ, Flower K, Everhart ET, Munro TA, Galloway GP, Cohen BM. Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial. Psychopharmacology (Berl). 2011 Apr; 214(4):933-9. PMID: 21140258.
      View in: PubMed
    16. Baggott MJ, Siegrist JD, Galloway GP, Robertson LC, Coyle JR, Mendelson JE. Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans. PLoS One. 2010 Dec 02; 5(12):e14074. PMID: 21152030.
      View in: PubMed
    17. Baggott MJ, Coyle JR, Erowid E, Erowid F, Robertson LC. Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug Alcohol Depend. 2011 Mar 01; 114(1):61-7. PMID: 21035275.
      View in: PubMed
    18. Garrison KJ, Coyle JR, Baggott MJ, Mendelson J, Galloway GP. Imagery scripts and a computerized subtraction stress task both induce stress in methamphetamine users: a controlled laboratory study. Subst Abuse. 2010; 4:53-60. PMID: 22879743.
      View in: PubMed
    19. Baggott MJ, Erowid E, Erowid F, Galloway GP, Mendelson J. Use patterns and self-reported effects of Salvia divinorum: an internet-based survey. Drug Alcohol Depend. 2010 Oct 01; 111(3):250-6. PMID: 20627425.
      View in: PubMed
    20. Flower K, Li L, Chen CY, Baggott MJ, Galloway GP, Mendelson J. Efficacy, safety, and ethics of cosmetic neurology far from settled. Clin Pharmacol Ther. 2010 Oct; 88(4):461-3. PMID: 20856245.
      View in: PubMed
    21. Galloway GP, Singleton EG, Buscemi R, Baggott MJ, Dickerhoof RM, Mendelson JE. An examination of drug craving over time in abstinent methamphetamine users. Am J Addict. 2010 Nov-Dec; 19(6):510-4. PMID: 20958846.
      View in: PubMed
    22. Li L, Lopez JC, Galloway GP, Baggott MJ, Everhart T, Mendelson J. Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose. Ther Drug Monit. 2010 Aug; 32(4):504-7. PMID: 20592647.
      View in: PubMed
    23. Connelly WM, Baggott MJ. Role of endocannabinoids in 5-HT2 receptor-mediated effects. J Neurophysiol. 2009 Jan; 101(1):5-7. PMID: 19004992.
      View in: PubMed
    24. Dufka F, Galloway G, Baggott M, Mendelson J. The effects of inhaled L-methamphetamine on athletic performance while riding a stationary bike: a randomised placebo-controlled trial. Br J Sports Med. 2009 Oct; 43(11):832-5. PMID: 18981044.
      View in: PubMed
    25. Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl). 2002 Aug; 162(4):396-405. PMID: 12172693.
      View in: PubMed
    26. Baggott MJ. Preventing problems in Ecstasy users: reduce use to reduce harm. J Psychoactive Drugs. 2002 Apr-Jun; 34(2):145-62. PMID: 12691205.
      View in: PubMed
    27. Vollenweider FX, Jones RT, Baggott MJ. Caveat emptor: editors beware. Neuropsychopharmacology. 2001 Apr; 24(4):461-3. PMID: 11310414.
      View in: PubMed
    28. Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann Intern Med. 2000 Dec 19; 133(12):969-73. PMID: 11119398.
      View in: PubMed
    29. Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E, Zehnder J. Chemical analysis of ecstasy pills. JAMA. 2000 Nov 01; 284(17):2190. PMID: 11056589.
      View in: PubMed
    30. Baggott M, Mendelson J, Jones R. More about parkinsonism after taking ecstasy. N Engl J Med. 1999 Oct 28; 341(18):1400-1. PMID: 10577097.
      View in: PubMed
    31. Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers. Psychopharmacology (Berl). 1999 Jan; 141(1):37-46. PMID: 9952063.
      View in: PubMed
    32. Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, Baggott MJ. Buprenorphine and naloxone interactions in opiate-dependent volunteers. Clin Pharmacol Ther. 1996 Jul; 60(1):105-14. PMID: 8689806.
      View in: PubMed
    33. Richards JB, Baggott MJ, Sabol KE, Seiden LS. A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task. Brain Res. 1993 Nov 12; 627(2):254-60. PMID: 8298969.
      View in: PubMed
    Baggott's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (145) concept(s)
    _
    Co-Authors Expand Description
    See all (4) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Physical Neighbors Expand Description
    _